Medical/Pharmaceuticals
Xinhua Silk Road: 52nd Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China's Jiangxi
BEIJING, Oct. 20, 2021 /PRNewswire/ -- The 52nd Zhangshu National Traditional
Chinese Materia MedicaTrade
2021-10-20 17:27
4111
A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy.
DAEJEON, South Korea, Oct. 20, 2021 /PRNewswire/ -- On September 2, 2021, a
scientific paper from GenKOre on the new hypercompact CRISPR system called
CRISPR/Cas12f-GE was published in an online issue of Nature Biotechnology (IF
54.9), one of the world's top-tier biotechnology journals.
2021-10-20 15:31
4105
Getinge Q3 Report 2021: "Strong order intake and our remediation measures completed in Germany"
GOTHENBURG, Sweden, Oct. 20, 2021 /PRNewswire/ -- "Organic order intake increased by more than 20% in the third quarter, with a strong performance in all business areas and regions," says Mattias Perjos, President & CEO at Getinge. "Our cash flow remains strong, meaning that we have strengthened ...
2021-10-20 15:19
4147
Action for bone health is needed now more than ever, urges IOF
NYON, Switzerland, Oct. 20, 2021 /PRNewswire/ -- A backlog in osteoporosis assessments, treatment delays, and sedentary indoor lifestyles: these are just several ways in which the Covid-19 pandemic has impacted bone health and disrupted global osteoporosis care. Osteoporosis is a common bone dis...
2021-10-20 13:30
3899
Bill & Melinda Gates Foundation Commits up to $120 Million to Accelerate Access to COVID-19 Drug for Lower-Income Countries, Calls on Other Donors to Mobilize Resources
Financial commitment aims to secure dedicated, low-cost supply of molnupiravir, if the drug is authorized by regulators; builds on long-term efforts to increase access to tests, treatments, vaccines SEATTLE, Oct. 20, 2021 /PRNewswire/ -- The Bill & Melinda Gates Foundation announced today a comm...
2021-10-20 13:29
3075
Phillips-Medisize Increases Global Manufacturing Capacity, Capabilities and Collaborations to Drive Drug Delivery, Diagnostic and MedTech Innovations
- Medical and pharmaceutical solutions leader poised to scale manufacturing from new and expanded production facilities and R&D centers inPoland, China and U.S. - End-to-end capabilities optimize design, development and manufacturing of world-class healthcare products and solutions while reducin...
2021-10-20 10:00
3950
CStone received China NMPA IND acceptance for lorlatinib in Chinese patients with ROS1-positive advanced NSCLC
SUZHOU, China, Oct. 20, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology therapies and precision medicines, today announced that the investigational new drug (...
2021-10-20 08:00
4473
Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China
* China Phase I study of BBT-401 had its first subject dosed in Chengdu, China * The company seeks to accelerate its business development activities with Daewoong, their partner for the development and commercialization of BBT-401 in 22 Asian countries SEONGNAM, South Korea and CHENGDU, China, ...
2021-10-20 07:00
2153
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program
- Clinical trial to enroll patients with early-stage Multiple Systems Atrophy (MSA) - - Expanding bioMUSE Natural History Study - MELBOURNE, Australia and SAN FRANCISCO, Oct. 19, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology c...
2021-10-20 05:08
2546
Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer
HONG KONG and NEW YORK, Oct. 19, 2021 /PRNewswire/ -- Insilico Medicine, an end-to-end AI-powered drug discovery company, today announced the appointment of Dr.Michelle Chen to the company's position of Chief Business Officer. In this role, Dr. Chen will oversee the company's corporate strategie...
2021-10-19 23:30
4156
Excelra Announces Addition of Sudip Nandy to its Board of Directors
HYDERABAD, India, Oct. 19, 2021 /PRNewswire/ -- Excelra, a leading Data and Analytics provider for Life Science organizations, announced the appointment of Sudip Nandy to the company's board of directors effective 1st October 2021. Mr. Nandy is an acclaimed business leader with over 30 years of e...
2021-10-19 21:00
8122
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody
DAEJEON, South Korea, Oct. 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the patent for PMC-309, one of the Company's first immuno-oncology assets, has been ...
2021-10-19 20:00
2151
Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase II Trial in Patients with Thyroid Eye Disease
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, the clinical trial of its anti-FcRn antibody, batoclimab (HBM9161), has completed the first dosing of first patient in phase II trial for the treatment ...
2021-10-19 17:52
2571
Qiming's Portfolio Company Microtech Medical Lists on Main Board of HKEx
SHANGHAI, Oct. 19, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Microtech Medical (SEHK:2235), a leading Chinese diabetes management medical device maker, today listed on the main board of the Hong Kong Stock Exchange. The issue price isHK$ 30.5 per share. The stock opened a...
2021-10-19 14:07
5083
InnoCare Announces Approval of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 in China
BEIJING, Oct. 19, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) announced today that the Company has received Investigational New Drug (IND) approval from the NMPA for itsSHP2 (Src Homology 2 domain containing protein tyrosine phosphatase) allosteric inhibitor ICP-189, which is the company's...
2021-10-19 12:56
2403
Prenetics To Be The Exclusive RT-PCR COVID-19 Testing Partner For The Standard Chartered Hong Kong Marathon 2021
HONG KONG, Oct. 19, 2021 /PRNewswire/ -- Prenetics (the "Company"), a global leader in genomic and diagnostic testing, announced today it has been appointed as the official RT-PCR COVID-19 testing partner for the Standard Chartered Hong Kong Marathon 2021, which is set to take place onOctober 24....
2021-10-19 09:00
3170
CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiotic Program to Combat Resistant N. gonorrhoeae Infections
LAUSANNE, Switzerland and BOSTON, Oct. 19, 2021 /PRNewswire/ -- Debiopharm (
www.debiopharm.com
2021-10-19 09:00
2248
DiscGenics Honored by Goldman Sachs for Entrepreneurship
Chairman and CEO Flagg Flanagan Among 100 Most Intriguing Entrepreneurs at 2021 Builders + Innovators Summit SALT LAKE CITY, Oct. 19, 2021 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and ...
2021-10-19 07:34
3110
Australian businesses invited to advance the future of healthcare technologies in the Medtronic APAC Innovation Challenge
SYDNEY, Oct. 19, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in healthcare technology, invites Australian businesses to participate in the newly launchedMedtronic APAC Innovation Challenge (MAIC). Providing an opportunity for innovators in the region to pitch and advance the...
2021-10-19 06:51
4277
The Journal of Medicinal Chemistry Publishes Study Showing Potential of the Potent EED Inhibitor EEDi-5273 (APG-5918) to Achieve Complete Tumor Regression by Modulating the Epigenetics
SUZHOU, China, and ROCKVILLE, Md., Oct. 18, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that a research team led by Prof. Shaomeng Wang, ...
2021-10-18 22:42
8560
Week's Top Stories
Most Reposted
Mastercard elevates premium travel with Asia Pacific's first Taste by Priceless dining club at Hong Kong International Airport
[Picked up by 319 media titles]
2026-08-05 11:34
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
[Picked up by 309 media titles]
2026-07-30 10:45
Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
[Picked up by 295 media titles]
2026-08-04 07:00
J.P. Morgan Private Bank Earns Record 10 Accolades at The Asset Triple A Private Capital Awards 2026
[Picked up by 294 media titles]
2026-07-30 15:00Most Read
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
2026-07-30 10:45
19715
